Arixtra and Temsirolimus drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Arixtra (fondaparinux sodium) and Temsirolimus (temsirolimus). Common drug interactions include urinary tract infection among females and cerebral haemorrhage among males.

The phase IV clinical study analyzes what interactions people have when they take Arixtra and Temsirolimus. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.

What is Arixtra?

Arixtra has active ingredients of fondaparinux sodium. It is often used in deep venous thrombosis. eHealthMe is studying from 9,830 Arixtra users. Check the latest studies of Arixtra.

What is Temsirolimus?

Temsirolimus has active ingredients of temsirolimus. eHealthMe is studying from 3,573 Temsirolimus users. Check the latest studies of Temsirolimus.

On Jul, 14, 2026

20 people who take Arixtra and Temsirolimus together, and have interactions are studied.

Arixtra and Temsirolimus drug interactions.

What are the common drug interactions of Arixtra and Temsirolimus, by gender? *:

female:

Urinary tract infection
Death
Diarrhoea
Proctalgia (pain in the rectum)
Blood creatinine increased
Disease progression
Dysphagia (a condition in which swallowing is difficult or painful)
Dyspnoea (difficult or laboured respiration)
Escherichia urinary tract infection (urinary tract infection by escherichia coli)
Intracranial pressure increased (high pressure inside the skull and thus in the brain tissue and cerebrospinal fluid)

male:

Cerebral haemorrhage (bleeding within the brain)
Erysipelas (bacterial skin infection)
Anaemia (lack of blood)
Leukocytosis (increased white blood cells)
Pleural effusion (water on the lungs)
Splenic haemorrhage (bleeding from spleen)
Thrombocythaemia (an increased number of platelets in the circulating blood)
Hypoxia (low oxygen in tissues)
Klebsiella infection
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)

What are the common drug interactions of Arixtra and Temsirolimus, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Anaemia (lack of blood)
Leukocytosis (increased white blood cells)
Pleural effusion (water on the lungs)
Splenic haemorrhage (bleeding from spleen)
Thrombocythaemia (an increased number of platelets in the circulating blood)

50-59:

Lung infection

60+:

Cerebral haemorrhage (bleeding within the brain)
Erysipelas (bacterial skin infection)
Diarrhoea
Multi-organ failure (multisystem organ failure)
Proctalgia (pain in the rectum)
Blood creatinine increased
Disease progression
Dysphagia (a condition in which swallowing is difficult or painful)
Dyspnoea (difficult or laboured respiration)
Escherichia urinary tract infection (urinary tract infection by escherichia coli)

What are the existing conditions these people have? *

Pancreatic Carcinoma (pancreatic cancer): 6 people, 30.00%
Pain: 5 people, 25.00%
Metastatic Malignant Melanoma (spreadable cancer tumour of melanine): 5 people, 25.00%
Thrombosis (formation of a blood clot inside a blood vessel): 4 people, 20.00%
Pulmonary Embolism (blockage of the main artery of the lung): 4 people, 20.00%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 4 people, 20.00%
Glioblastoma (most common and most aggressive malignant primary brain tumour in humans): 4 people, 20.00%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 4 people, 20.00%
Brain Oedema (excess accumulation of fluid in the intracellular or extracellular spaces of the brain): 4 people, 20.00%
Renal Cell Carcinoma (a kidney cancer): 2 people, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Arixtra and Temsirolimus?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously